Print this page
-
A Phase II Study of U3-1402 in Patients with Metastatic Breast Cancer.
Protocol: 042103Principal Investigator:
- Deborah Toppmeyer M.D. (Rutgers University)
Applicable Disease Sites: Breast -
A Double-Blinded, Phase III Randomized Trial of T-DM1 Compared with T-DM1 and Tucatinib.
Protocol: 042106Principal Investigator:
- Coral Omene MD, PhD (Rutgers University)
Applicable Disease Sites: Breast -
The Women's Circle of Health Study.
Protocol: 130404Principal Investigator:
- Elisa Bandera M.D., Ph.D. (Rutgers University)
Applicable Disease Sites: Breast - Female -
INFORM Extended
Protocol: 042101Principal Investigator:
- Deborah Toppmeyer M.D. (Rutgers University)
Applicable Disease Sites: Breast -
Adapting and Implementing Evidence-Based Breast Cancer Follow-up in Primary Care.
Protocol: 132103Principal Investigator:
- Shawna Hudson Ph.D. (Rutgers University)
Applicable Disease Sites: Breast -
Video Education with Result Dependent dIsclosure (VERDI)
Protocol: 042207Principal Investigator:
- Deborah Toppmeyer M.D. (Rutgers University)
Applicable Disease Sites: Pancreas
Melanoma, Skin
Colon
Ovary
Soft Tissue
Prostate
Kidney
Breast